Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
French cross-cultural adaptation and validity of the Moorong Self-Efficacy scale: the MSES-FR, a measure of Self-Efficacy for French people with spinal cord injury.
Gounelle M, Cousson-Gelie F, Nicolas B, Kerdraon J, Gault D, Tournebise H, Goossens D, Leynaert V, Middleton J, Coffy A, Gelis A. Gounelle M, et al. Among authors: kerdraon j. Disabil Rehabil. 2022 Dec;44(25):8066-8074. doi: 10.1080/09638288.2021.2003452. Epub 2021 Nov 22. Disabil Rehabil. 2022. PMID: 34802337
Prospective multicentre observational study assessing the tolerance and perception of patients using the Liquick Base catheter with an Ergothan tip.
Gamé X, Gania L, Perrouin-Verbe B, Costa P, Marcelli F, Wolff N, Scribe MJ, Kerdraon J, Goossens D, Manunta A, Guy L, Rouleaud S, Charvier K, Castel-Lacanal E. Gamé X, et al. Among authors: kerdraon j. Prog Urol. 2020 Dec;30(17):1134-1139. doi: 10.1016/j.purol.2020.09.024. Epub 2020 Nov 3. Prog Urol. 2020. PMID: 33153881
Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.
Gamé X, Mouracade P, Chartier-Kastler E, Viehweger E, Moog R, Amarenco G, Denys P, De Seze M, Haab F, Karsenty G, Kerdraon J, Perrouin-Verbe B, Ruffion A, Soler JM, Saussine C. Gamé X, et al. Among authors: kerdraon j. J Pediatr Urol. 2009 Jun;5(3):156-64. doi: 10.1016/j.jpurol.2009.01.005. Epub 2009 Mar 4. J Pediatr Urol. 2009. PMID: 19264554 Review.
[Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].
Perrouin-Verbe B, Ruffion A, Gamé X, Denys P, Kerdraon J, Karsenty G, de Sèze M, Haab F, Saussine C, Soler JM, Amarenco G, Chartier-Kastler E. Perrouin-Verbe B, et al. Among authors: kerdraon j. Prog Urol. 2009 Jun;19(6):372-82. doi: 10.1016/j.purol.2009.02.006. Epub 2009 Apr 3. Prog Urol. 2009. PMID: 19467455 French.
[Drug therapy of bladder dysfunction].
Caremel R, Cornu JN, Kerdraon J, Castel-Lacanal E, Bastide C, Bruyere F, Guy L, Karsenty G. Caremel R, et al. Among authors: kerdraon j. Prog Urol. 2013 Nov;23(15):1271-86. doi: 10.1016/j.purol.2013.09.020. Epub 2013 Oct 24. Prog Urol. 2013. PMID: 24183086 Review. French.
88 results